Literature DB >> 17058522

Association of two genetic variations of lipoprotein lipase, S447X and Hind III, with coronary artery disease and hypertriglyceridemia.

Daria Pasalić1, Goran Ferencak, Branka Grsković, Mihajlo Sesto, Ana Stavljenić-Rukavina.   

Abstract

This study was performed to assess the effect of the S447X and Hind III lipoprotein lipase gene polymorphisms on development of coronary artery disease and hypertriglyceridemia. The study included 132 patients and 98 healthy control subjects of Croatian descent. The lipoprotein lipase S447X polymorphism was associated with coronary artery disease and hypertriglyceridemia, as indicated by the lower frequency of S447 allele in the patient group (p = 0.005) and odds ratio (O.R = 0.40, p = 0.006). The patient and control groups also showed a significant difference in the distribution of Hind III/S447X genotype combinations (p = 0.013). There were no significant associations with lipid parameters for any genotype or genotype combination in the patient group. Frequencies of the S447X polymorphism and S447X/Hind III combinations differed between the CAD/TG and control group, thus these polymorphisms may be associated with CAD and hypertriglyceridemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17058522

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  3 in total

1.  Synergistic effect between lipoprotein lipase and apolipoprotein C3 genes in determining the severity of coronary artery disease.

Authors:  Tarek A Abd-El-Aziz; Randa H Mohamed; Amal S El-Shal
Journal:  J Cardiovasc Transl Res       Date:  2013-02-02       Impact factor: 4.132

Review 2.  Lipoprotein Lipase (LPL) Polymorphism and the Risk of Coronary Artery Disease: A Meta-Analysis.

Authors:  Li Xie; You-Mei Li
Journal:  Int J Environ Res Public Health       Date:  2017-01-16       Impact factor: 3.390

3.  Associations between LPL gene polymorphisms and coronary artery disease: evidence based on an updated and cumulative meta-analysis.

Authors:  Wen-Qi Ma; Ying Wang; Xi-Qiong Han; Yi Zhu; Nai-Feng Liu
Journal:  Biosci Rep       Date:  2018-02-19       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.